Latest total assets for IMMVF: $48M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Immunovia AB posts a total assets of $48M as of June 2026. That compares with $35M in the prior-year period — up 37.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Immunovia AB's total assets was $35M. The latest reading is $48M — a 37.8% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
Total Assets is one piece of Immunovia AB's financial statement story. At $48M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for IMMVF's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Immunovia AB's other metric pages and overview cover the third.